Clinical trial
A Prospective Multi-Center, Evaluator- and Subject- Blinded, Randomized Study to Evaluate the Safety and Effectiveness of NOA LIFT Compared to JUVÉDERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds
NCT07794878 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multi-Center, Evaluator- and Subject- Blinded, Randomized Study to Evaluate the Safety and Effectiveness of NOA LIFT Compared to JUVÉDERM VOLIFT With Lidocaine for the Correction of Nasolabial Folds
- Lead sponsor
- AbbVie
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- August 19, 2026
- Completion date
- August 31, 2028
- Enrollment
- 288 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
nasolabial folds